GSK Hit With Suit Over Avodart's Prostate Cancer Risks

Law360, New York (November 29, 2012, 4:58 PM EST) -- GlaxoSmithKline PLC was hit with a product liability suit in Pennsylvania state court Wednesday claiming the pharmaceutical giant concealed or downplayed the potentially life-threatening side effects of its prostate drug Avodart, which the plaintiff claims caused him to develop prostate cancer.

Texas resident Richard Jannarone and his wife, Susan Jannarone, brought suit claiming GSK knew of Avodart’s health risks, yet continued to develop, market and sell the drug as a treatment for benign prostatic hyperplasia to boost its own profits. Richard Jannarone claims he was prescribed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.